See the ZEUS smart automation solution for SARS-CoV-2 antibody testing in action.

45 years of diagnostic testing expertise and seamless automation – a powerful combination!

The expertise that ZEUS Scientific has gained from over 45 years of developing and manufacturing diagnostic tests was instrumental in creating the unique dual antigen design of the ZEUS ELISA SARS-CoV-2 Antibody Test Systems.  Utilizing these tests with the Dynex AGILITY® fully automated ELISA system provides you with a powerful and simple combination for your testing needs.  As the world continues to fight the COVID-19 pandemic, SARS-CoV-2 antibody testing remains an important tool.

Both the ZEUS ELISA SARS-CoV-2 IgG and Total (IgG, IgM, IgA) Antibody Test Systems have been authorized by the FDA for Emergency Use (EUA) and are designed to detect antibodies against both the nucleocapsid and spike S1-RBD proteins, allowing for detection of both immunized and natural immunity to SARS-CoV-2. The tests can be used individually or as part of a testing scheme. In addition, these tests are simple and easy to use with the SmartKit® Gold packaging allowing for easy loading onto the Dynex AGILITY® fully automated ELISA system.

See for yourself how easy it is.

The power of combining the ZEUS ELISA SARS-CoV-2 Antibody Test Systems and the Dynex AGILITY® fully automated ELISA system is in the details.

The ZEUS Smart Automation Solution for SARS-CoV-2 Antibody Testing

See the simplified ZEUS SARS-CoV-2 workflow with the Dynex AGILITY®:

Unique ZEUS dual antigen assay design recognizes antibodies to both the N-protein and the S1-RBD proteins of SARS-CoV-2, allowing for detection of antibodies produced by a natural SARS-CoV-2 infection and/or from vaccination. Simple, direct loading with SmartKit® Gold Packaging reduces costs associated with disposable plastics and avoids data entry errors, ultimately saving technician's time. Streamlined throughput using the ZEUS Universal ELISA Protocol Proprietary ZEUS SAVe Diluent® changes color when serum is added so no well is missed! High throughput (up to 810 reportable results/8 hours) provides fast results in formats that fit the laboratory’s needs. Traceability with 2D Barcoding throughout the workflow eliminates transcription errors and adds confidence to your results.

---

 

Both the ZEUS ELISA SARS-CoV-2 Test Systems are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Both the ZEUS SARS-CoV-2 IgG Test Systems and ZEUS SARS-CoV-2 Total Antibody Test Systems have FDA EUA to run manually or with the Dynex Agility®, DSX® and DS2®.

 

Test with Confidence. Test with ZEUS.

Learn more at zeuscovid.com or contact our sales team for pricing today!

 

Sincerely,

The ZEUS Scientific Family

 

_{FDA EUA Disclaimer: These tests have been authorized only for the presence of IgG antibodies and Total antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests have been authorized by FDA under an EUA for use by authorized laboratories. These tests have not been FDA cleared or approved; These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.}

Back Share